VTGN - VistaGen Therapeutics Q4 Earnings Preview
2024-06-10 13:02:56 ET
More on VistaGen Therapeutics
- Vistagen Therapeutics: A Pipeline With Potential In Anxiety And Depression
- Vistagen Therapeutics: Initial Analysis Of Fasedienol Points To Bullish
- Why VistaGen Therapeutics Is A Buy: Fasedienol Potential For Anxiety Treatments
- Vistagen reports positive results for mental fatigue treatment
- Seeking Alpha’s Quant Rating on VistaGen Therapeutics